Manal Ali Elzoheiry

Dr. Manal Ali Elzoheiry

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MSMaryamsadat Seyedsadr
Maryamsadat Seyedsadr
YWYan Wang
Yan Wang
MEManal Ali Elzoheiry
Manal Ali Elzoheiry
SGSowmya Shree Gopal
Sowmya Shree Gopal
SJSoohwa Jang
Soohwa Jang
SMSilva Markovic-Plese
Silva Markovic-Plese
The objective of this study is to examine IL-11-induced mechanisms of inflammatory cell migration to the central nervous system (CNS). We report that IL-11 is produced at highest frequency by myeloid cells among the peripheral blood mononuclear cell (PBMC) subsets. Patients with relapsing–remitting multiple sclerosis (RRMS) have an increased frequency of IL-11 + monocytes, IL-11 + and IL-11R + CD4 + lymphocytes, and IL-11R + neutrophils in comparison to matched healthy controls. IL-11 + and granulocyte-macrophage colony-stimulating factor (GM-CSF) + monocytes, CD4 + lymphocytes, and neutrophils accumulate in the cerebrospinal fluid (CSF). The effect of IL-11 in-vitro stimulation, examined using single-cell RNA sequencing, revealed the highest number of differentially expressed genes in classical monocytes, including up-regulated NFKB1, NLRP3, and IL1B . All CD4 + cell subsets had increased expression of S100A8/9 alarmin genes involved in NLRP3 inflammasome activation. In IL-11R + -sorted cells from the CSF, classical and intermediate monocytes significantly up-regulated the expression of multiple NLRP3 inflammasome–related genes, including complement, IL18 , and migratory genes ( VEGFA/B ) in comparison to blood-derived cells. Therapeutic targeting of this pathway with αIL-11 mAb in mice with RR experimental autoimmune encephalomyelitis (EAE) decreased clinical scores, CNS inflammatory infiltrates, and demyelination. αIL-11 mAb treatment decreased the numbers of NFκBp65 + , NLRP3 + , and IL-1β + monocytes in the CNS of mice with EAE. The results suggest that IL-11/IL-11R signaling in monocytes represents a therapeutic target in RRMS.

30 July 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MEManal Ali Elzoheiry
Manal Ali Elzoheiry
ADAkram A. Da'dara
Akram A. Da'dara
RBRita Bhardwaj
Rita Bhardwaj
QWQiang Wang
Qiang Wang
MAManar S. Azab
Manar S. Azab
PSPatrick J. Skelly
Patrick J. Skelly
Schistosomes are parasitic flatworms that infect the vasculature of >200 million people around the world. These long-lived parasites do not appear to provoke blood clot formation or obvious inflammation around them in vivo. Proteins expressed at the host–parasite interface (such as Schistosoma mansoni alkaline phosphatase, SmAP) are likely key to these abilities. SmAP is a glycoprotein that hydrolyses the artificial substrate p-nitrophenyl phosphate in a reaction that requires Mg2+ and at an optimal pH of 9. SmAP additionally cleaves the nucleoside monophosphates AMP, CMP, GMP, and TMP, all with a similar Km (~600–650 μM). Living adult worms, incubated in murine plasma for 1 h, alter the plasma metabolome; a decrease in sphingosine-1-phosphate (S1P) is accompanied by an increase in the levels of its component parts—sphingosine and phosphate. To test the hypothesis that schistosomes can hydrolyze S1P (and not merely recruit or activate a host plasma enzyme with this function), living intravascular life-stage parasites were incubated with commercially obtained S1P and cleavage of S1P was detected. Parasites whose SmAP gene was suppressed using RNAi were impaired in their ability to cleave S1P compared to controls. In addition, recombinant SmAP hydrolyzed S1P. Since extracellular S1P plays key roles in controlling inflammation and platelet aggregation, we hypothesize that schistosome SmAP, by degrading S1P, can regulate the level of this bioactive lipid in the environment of the parasites to control these processes in the worm’s local environment. This is the first report of any parasite being able to cleave S1P.

18 April 2018 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
MEManal Ali Elzoheiry
Manal Ali Elzoheiry
ADAkram A. Da'Dara
Akram A. Da'Dara
ADArmelle M. Delaforcade
Armelle M. Delaforcade
SESamar N. El-Beshbishi
Samar N. El-Beshbishi
PSPatrick Skelly
Patrick Skelly
Schistosomes are intravascular parasitic platyhelminthes infecting > 200 million people globally and causing a debilitating disease, schistosomiasis. Despite the relatively large size of the adult worms and their disruption of blood flow, surprisingly, they do not appear to provoke thrombus formation around them in vivo. We hypothesize that proteins expressed at the host–parasite interface are key to this ability. Here, we functionally express an ectonucleotide pyrophosphatase/phosphodiesterase homologue, SmNPP5, that is expressed at the tegumental surface of intravascular Schistosoma mansoni. We report that SmNPP5, a known virulence factor for the worms, is a type one glycoprotein that cleaves the artificial substrate p-Nph-5′-TMP in a reaction that requires cations and at an optimal pH of 9. Using immunolocalization and enzyme activity measurements, we confirm that SmNPP5 is exclusively expressed at the host interactive surface of all intravascular life stages. SmNPP5 inhibits platelet aggregation in a dose-dependent manner, as measured by multiple electrode aggregometry (MEA) using whole blood. Inhibition is apparent when either collagen or adenosine diphosphate (ADP) is used as agonist but is lost following heat treatment of SmNPP5. Unlike its mammalian homologue, NPP5, the schistosome protein cleaves ADP and with a Km of 246 ± 34 µM. In sum, SmNPP5 is expressed in the intravascular environment where it can degrade ADP and act as an anticoagulant. In this manner, the protein likely helps limit blood clot formation around the worms in vivo to permit the parasites free movement within the vasculature.

1 September 2019 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
MEManal Ali Elzoheiry
Manal Ali Elzoheiry
ADAkram A. Da’dAra
Akram A. Da’dAra
CNCatherine S. Nation
Catherine S. Nation
SESamar N. El-Beshbishi
Samar N. El-Beshbishi
PSPatrick Skelly
Patrick Skelly

3 November 2025 in Blood Advances
Verified
Journal Article
Open access
MEManal Ali Elzoheiry
Manal Ali Elzoheiry
CDCarol A. Dangelmaier
Carol A. Dangelmaier
DVDhruv N. Vajipayajula
Dhruv N. Vajipayajula
MWMonica N. Wright
Monica N. Wright
Alexander Y. TsygankovAlexander Y. Tsygankov
Alexander Y. Tsygankov
SKSatya P. Kunapuli
Satya P. Kunapuli
Spleen tyrosine kinase (Syk) is expressed in a variety of hematopoietic cells. Its phosphorylation regulates downstream signaling events upon stimulation of receptors containing an immunoreceptor tyrosine-based activation motif (ITAM), like glycoprotein VI, or a hemITAM, including the C-type lectin-like receptor 2 (CLEC-2). This study focuses on the role of a specific phosphorylation site, tyrosine 317, in the regulation of Syk function. Tyrosine 317 is located in the linker region of Syk that separates the amino-terminal, tandem pair of SH2 domains from the carboxyl-terminal catalytic domain. The amino acid sequence surrounding phosphotyrosine 317 binds to the matching recognition sequence in the tyrosine kinase–binding domain of Cbl, an E3 ubiquitin-protein ligase. To evaluate the function of this phosphorylation site, we generated mice expressing Syk(Y317F) using the CRISPR/Cas9 technique. Platelets from homozygous Syk(Y317F) mice showed enhancement of platelet signaling and physiological responses after stimulation with collagen-related peptide (CRP) and CLEC-2 cross-linking. This enhancement did not occur after stimulation with AYPGKF, a protease-activated receptor 4 agonist, or 2-methylthioadenosine diphosphate, a purinergic agonist. CRP- or CLEC-2 monoclonal antibody–induced downstream signaling events, including phosphorylation of LAT and phospholipase C γ2, were enhanced in Syk(Y317F) platelets compared with platelets from wild-type (WT) littermates. Besides an increase in platelet responses in vitro, the time to occlusion in the FeCl3 injury model was decreased in Syk(Y317F) mice compared with WT littermates. However, there was no significant difference in the tail bleeding times. Taken together, these data reveal that tyrosine 317 negatively regulates Syk signaling and functions in mouse platelets.

26 January 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
CNCatherine S. Nation
Catherine S. Nation
ADAkram A. Da'dara
Akram A. Da'dara
MEManal Ali Elzoheiry
Manal Ali Elzoheiry
PSPatrick Skelly
Patrick Skelly
Schistosomes (blood flukes) can survive in the bloodstream of their hosts for many years. We hypothesize that proteins on their host-interactive surface impinge on host biochemistry to help ensure their long-term survival. Here, we focus on a surface ectoenzyme of Schistosoma mansoni, designated SmNPP5. This ~53 kDa glycoprotein is a nucleotide pyrophosphatase/phosphodiesterase that has been previously shown to: (1) cleave adenosine diphosphate (ADP) and block platelet aggregation; and (2) cleave nicotinamide adenine dinucleotide (NAD) and block NAD-induced T cell apoptosis in vitro. T cell apoptosis can additionally be driven by extracellular adenosine triphosphate (ATP). In this work, we show that adult S. mansoni parasites can inhibit this process. Further, we demonstrate that recombinant SmNPP5 alone can both cleave ATP and impede ATP-induced T cell killing. As immunomodulatory regulatory T cells (Tregs) are especially prone to the induction of these apoptotic pathways, we hypothesize that the schistosome cleavage of both NAD and ATP promotes Treg survival and this helps to create a less immunologically hostile environment for the worms in vivo.